Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine
- 31 August 1977
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 16 (7-8) , 485-488
- https://doi.org/10.1016/0028-3908(77)90005-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963Neuropharmacology, 1976
- Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymolepticsEuropean Journal of Pharmacology, 1975
- Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant propertiesPsychopharmacology, 1975
- A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitorsBritish Journal of Pharmacology, 1972
- Evidence for a specific monoamine oxidase associated with sympathetic nervesNeuropharmacology, 1971
- Rage reactions produced in rats by a combination of thymoleptics and monoamine oxidase inhibitorsPharmacological Research Communications, 1969
- Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramineBrain Research, 1969
- Blockade of the psychotic syndrome caused by nialamide in miceJournal of Pharmacy and Pharmacology, 1966